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ermination of cyclic adenosine monophosphate
(cAMP) signaling via the extracellular Ca
 
2
 
 
 
-sens-
ing receptor (CaR) was visualized in single CaR-
expressing  human embryonic kidney (HEK) 293 cells
using ratiometric ﬂuorescence resonance energy trans-
fer–dependent cAMP sensors based on protein kinase A
and Epac. Stimulation of CaR rapidly reversed or pre-
vented agonist-stimulated elevation of cAMP through a
dual mechanism involving pertussis toxin–sensitive G
 
 
 
i
 
and the CaR-stimulated increase in intracellular [Ca
 
2
 
 
 
].
In parallel measurements with fura-2, CaR activation
elicited robust Ca
 
2
 
 
 
 oscillations that increased in frequency
T
 
in the presence of cAMP, eventually fusing into a sustained
plateau. Considering the Ca
 
2
 
 
 
 sensitivity of cAMP accu-
mulation in these cells, lack of oscillations in [cAMP] dur-
ing the initial phases of CaR stimulation was puzzling.
Additional experiments showed that low-frequency, long-
duration Ca
 
2
 
 
 
 oscillations generated a dynamic staircase
pattern in [cAMP], whereas higher frequency spiking had
no effect. Our data suggest that the cAMP machinery in
HEK cells acts as a low-pass ﬁlter disregarding the rela-
tively rapid Ca
 
2
 
 
 
 spiking stimulated by Ca
 
2
 
 
 
-mobilizing
agonists under physiological conditions.
 
Introduction
 
cAMP controls crucial physiological cell functions such as cell
growth, differentiation, transcriptional regulation, and apopto-
sis. Levels of intracellular cAMP principally reflect a balance
between synthesis of the second messenger by adenylyl cy-
clases (ACs; activated through G protein–coupled receptors
[GPCRs] coupled to G
 
 
 
s
 
), degradation by phosphodiesterases
(PDEs), and the inhibitory action of pertussis toxin (PTX)–
sensitive G
 
 
 
i
 
-coupled receptors that serve to limit cAMP for-
mation by AC. The classical intracellular effector of the cAMP
signal is protein kinase A (PKA), a holotetrameric complex
that consists of two regulatory and two catalytic subunits that
dissociate upon cAMP binding. More recently, a second class
of intracellular cAMP targets has been identified: Epacs (ex-
change proteins activated by cAMP) are monomeric proteins
that undergo significant conformational changes upon cAMP
binding, allowing them to activate their target, Rap1 (Beavo and
Brunton, 2002). Aberrations in cAMP signaling or inappropriate
cAMP production can have serious pathological consequences
(e.g., tumor formation and heart failure). Therefore, understand-
ing how cAMP signals are terminated is just as important as un-
derstanding how they are generated in the first place.
In addition to inhibition through the classical PTX-sensitive
G
 
 
 
i
 
, intracellular Ca
 
2
 
 
 
 signaling pathways can exert powerful
modulatory actions on cAMP accumulation (for review see
Bruce et al., 2003). For example, some members of the exten-
sive superfamily of PDEs (particularly those belonging to the
PDE1 family) are activated by elevated intracellular Ca
 
2
 
 
 
(Houslay and Milligan, 1997; Goraya et al., 2004). In addition,
specific isoforms of AC have been shown to respond to physio-
logical changes in intracellular Ca
 
2
 
 
 
 with either activation or
inhibition of enzymatic activity (de Jesus Ferreira et al., 1998;
Chabardes et al., 1999; Cooper, 2003). Ca
 
2
 
 
 
 entering the cell
via store-operated channels preferentially regulates cAMP
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production by AC and has been proposed to be much more ef-
fective than Ca
 
2
 
 
 
 released from intracellular stores or influx
via other types of Ca
 
2
 
 
 
 channels (Cooper, 2003).
Conversely, the cAMP pathway can influence Ca
 
2
 
 
 
 sig-
naling at many levels. For example, PKA-dependent phos-
phorylation of intracellular release channels, such as the inositol
1,4,5-trisphosphate (InsP
 
3
 
) receptor, and Ca
 
2
 
 
 
 extrusion mech-
anisms, such as the plasma membrane Ca
 
2
 
 
 
 ATPase, can pow-
erfully shape Ca
 
2
 
 
 
 signals (for review see Bruce et al., 2003).
Reciprocal modulation by cAMP and Ca
 
2
 
 
 
 pathways will be
expected to generate unique patterns of signaling molecules
during concurrent activation of receptors linked to each of
these signal transduction cascades.
Agonist-induced oscillations in intracellular ([Ca
 
2
 
 
 
]
 
i
 
) are
a well-described phenomenon. Based on the fact that intracel-
lular Ca
 
2
 
 
 
 can augment or inhibit cAMP accumulation, it is
predicted that cAMP levels would fluctuate during oscillatory
Ca
 
2
 
 
 
 spiking in a cell type in which Ca
 
2
 
 
 
-dependent ACs or
PDEs were expressed (Cooper et al., 1995). Repetitive activa-
tion–inactivation cycles of the cAMP signaling pathway could
conceivably encode information that differed from large static
changes in the second messenger. Precisely this sort of regula-
tion has been shown to be operative for Ca
 
2
 
 
 
 in cells displaying
oscillatory Ca
 
2
 
 
 
 signaling events. The frequency, amplitude,
and duration of Ca
 
2
 
 
 
 spiking are known to differentially regu-
late key cellular functions such as gene transcription and the
activation of plasma membrane ion channels (Thorn et al.,
1993; Dolmetsch et al., 1998; Berridge et al., 2000).
In the present study we examined the interactions of the
extracellular Ca
 
2
 
 
 
-sensing receptor (CaR) with the cAMP sig-
nal transduction cascade. This widely expressed dimeric GPCR
was first cloned more than a decade ago from bovine parathy-
roid cells (Brown et al., 1993). Since that time, expression of
CaR has been demonstrated in several epithelial, glial, and neu-
ronal cell types. CaR is able to sense small fluctuations in the
extracellular [Ca
 
2
 
 
 
] within the physiological range (Brown and
MacLeod, 2001). Interestingly, this receptor is not strictly a
calcium sensor, as it can be stimulated by a variety of physio-
logically relevant divalent and polycationic compounds. These
compounds include Mg
 
2
 
 
 
; amino acids; and polyamines, such
as spermine and spermidine. CaR can also be activated through
allosteric modulation by synthetic small molecule “calcimimet-
ics,” such as NPS-R-467 (Conigrave et al., 2000; Hofer and
Brown, 2003; Breitwieser et al., 2004; Nemeth, 2004).
In CaR-transfected human embryonic kidney (HEK) 293
cells (HEK CaR) and in several other cell models in which the
receptor is expressed endogenously, CaR stimulation leads to ro-
bust oscillations in [Ca
 
2
 
 
 
]
 
i
 
 (Breitwieser and Gama, 2001; Young
and Rozengurt, 2002; De Luisi and Hofer, 2003). In addition to
this coupling to the phosphoinositide–InsP
 
3
 
–Ca
 
2
 
 
 
 signaling path-
way via G
 
 
 
q/11
 
, CaR has also been shown to inhibit cAMP pro-
duction (as measured using standard biochemical techniques)
through interactions with PTX-sensitive proteins, presumably
G
 
 
 
i
 
 (Chen et al., 1989; Chang et al., 1998). In the present study
we used recently introduced fluorescence resonance energy
transfer (FRET)–based fluorescent indicators for cAMP that al-
lowed us to visualize the inhibitory actions of CaR activation on
cAMP levels in single living HEK CaR cells in real time (Zac-
colo and Pozzan, 2002; Ponsioen et al., 2004). Our data confirm
that CaR interacts with PTX-sensitive G
 
 
 
i
 
 to inhibit AC in cells
stimulated with cAMP-generating agonists (prostaglandin E
 
2
 
[PGE
 
2
 
], vasoactive intestinal peptide [VIP], and isoproterenol).
Pharmacological and Western blot evidence suggest that
HEK 293 cells express principally Ca
 
2
 
 
 
-insensitive isoforms of
PDE (specifically, PDE4D3 and PDE4D5; Hoffmann et al.,
1999; Rich et al., 2001b). These cells are also known to express
multiple isoforms of AC (AC1, 3, 5, 6, 7, and 9 and soluble, bi-
carbonate-sensitive AC; Wayman et al., 1995; Ludwig and
Seuwen, 2002; Geng et al., 2005), of which some are Ca
 
2
 
 
 
 in-
hibitable (e.g., AC5 and AC6) and others are activated by Ca
 
2
 
 
 
or Ca
 
2
 
 
 
/calmodulin (e.g., AC1; soluble, bicarbonate-sensitive
AC; and possibly AC3). Because these enzyme subtypes may
have antagonistic actions on cAMP accumulation, it is difficult
to predict the effects of intracellular Ca
 
2
 
 
 
 elevations on cAMP
signaling. In this study we found that [Ca
 
2
 
 
 
]
 
i
 
 increases had a
substantial inhibitory effect on cAMP levels, suggesting the
prevailing action to be on Ca
 
2
 
 
 
-inhibitable AC. We also found
that in the presence of elevated cAMP, agonist-stimulated Ca
 
2
 
 
 
signaling is further augmented, providing additional inhibitory
feedback on cAMP generation. These factors conspire to make
CaR a particularly potent antagonist of cAMP generation.
Figure 1. Changes in the 480/535 nm FRET emission ratio in HEK CaR
cells expressing cAMP sensors in response to cAMP-elevating agonists.
(A) Cells expressing the PKA-based sensor (R-CFP   C-YFP) were stimu-
lated with 100 nM isoproterenol (ISO), 100 nM PGE2, and 100  M for-
skolin. (B) Ratio images corresponding to the time points (a–f) indicated
in the trace in A. The probe was excluded from the nuclear compart-
ment, although in this nonconfocal image, a signal emanating from
above and below the nucleus gives the appearance of a nuclear ratio
change. (C) Response of cells expressing Epac-based sensor to 5 nM
PGE2 and 100  M forskolin. 
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Because CaR agonists reliably elicit robust oscillations in
intracellular Ca
 
2
 
 
 
 in HEK CaR cells, we reasoned that [cAMP]
might also oscillate during CaR activation. However, although
both the amplitude and frequency of Ca
 
2
 
 
 
 oscillations, as mea-
sured by fura-2, were initially markedly enhanced by cAMP,
these Ca
 
2
 
 
 
 spikes were observed to eventually fuse into a sus-
tained plateau of elevated [Ca
 
2
 
 
 
]. At the same time, experiments
using the PKA probe and a system of artificially generated Ca
 
2
 
 
 
pulses revealed that dissociation of PKA (the major intracellular
target of the cAMP signal) is indifferent to patterns of rapid
Ca
 
2
 
 
 
 spiking, such as those elicited by an agonist in the ab-
sence of cAMP. In contrast, in the face of low-frequency, long-
duration Ca
 
2
 
 
 
 oscillations, a complex, descending staircase
pattern of cAMP (as measured by PKA dissociation) was un-
masked. These results show that the cAMP signaling machin-
ery in HEK cells can discriminate between different patterns of
Ca
 
2
 
 
 
 oscillations and is, in principle, immune to the rapid spik-
ing stimulated physiologically by Ca
 
2
 
 
 
-mobilizing agonists.
 
Results
 
Characterization of the cAMP probe in 
HEK 293 CaR cells
 
Several different types of fluorescent cAMP sensors have been
described previously (Adams et al., 1991; Zaccolo et al., 2000;
Zaccolo and Pozzan, 2002; DiPilato et al., 2004; Mongillo et
al., 2004; Ponsioen et al., 2004; Landa et al., 2005). Here we
used recently developed FRET sensors based on PKA (Zaccolo
and Pozzan, 2002) and Epac (Ponsioen et al., 2004) to contin-
uously monitor cAMP levels for extended periods of time in
single HEK CaR cells. Fig. 1 A shows that stimulation of endog-
enous 
 
 
 
-adrenoceptors using 100 nM isoproterenol produced
rapid  and reversible elevation in the FRET ratio. Repeated
stimulation of prostanoid receptors (EP
 
2
 
/EP
 
4
 
) with 100 nM of
the inflammatory mediator PGE
 
2
 
 yielded largely reproducible
responses in the same cell. This agonist dose generally caused
ratio responses that were smaller than the saturating activation
elicited by a supramaximal dose (100 
 
 
 
M) of forskolin. This
stimulation protocol was therefore used for much of the re-
mainder of the study (typical of results from 32 cells in five ex-
periments). Fig. 1 B shows pseudocolor images of the 480/535
nm FRET emission ratio of the PKA-based sensor, correspond-
ing to the plot shown in Fig. 1 A. CFP- and YFP-labeled PKA
subunits were distributed throughout the cytoplasm in trans-
fected cells but were excluded from the nuclear compartment
(not depicted). Significantly, because of the high sensitivity
of these FRET-based techniques, we were able to detect ra-
tio changes in response to low nanomolar concentrations of
cAMP-generating agonists (e.g., 6.25 nM VIP or 10 nM iso-
proterenol; not depicted). One drawback, in fact, of the high
sensitivity of these probes is that it is possible to saturate the in-
dicators when GFP-tagged PKA subunits are dissociated to the
maximal extent, even though intracellular cAMP continues to
rise. This issue is discussed further on the following page. We
also used a second type of cAMP probe based on Epac that ex-
hibits a faster response time (Ponsioen et al., 2004). As illus-
trated in Fig. 1 C, reversible ratio changes after stimulation
with 5 nM PGE
 
2
 
 were readily discriminated in HEK CaR cells
using this sensor.
 
Role of CaR in terminating cAMP 
signaling
 
We next took advantage of the extraordinary sensitivity of
these cAMP indicators to examine how activation of CaR in-
fluenced cAMP signaling. Fig. 2 A shows that the elevation of
the emission ratio induced by 100 nM PGE
 
2
 
 was completely
abolished by brief preexposure to NPS-R-467, a specific syn-
thetic allosteric activator of CaR (
 
n
 
 
 
  
 
38 cells in six experi-
ments; Nemeth, 2004). This calcimimetic by itself did not have
any effect on cAMP levels, as measured by FRET. The data in
Fig. 2 B further support this result. In the presence of the CaR
agonist spermine, an extremely high dose (3  M) of PGE2 pro-
duced only a very small transient increase in the ratio, followed
by a small undershoot, showing that CaR is extremely effective
in inhibiting cAMP production. The cAMP signal was partially
recovered after spermine washout. Prestimulation of CaR with
spermine or 3 mM Ca
2  was able to completely abolish the ratio
increase when a lower dose (100 nM) of PGE2 was applied
Figure 2. Stimulation of HEK CaR cells with CaR agonists prevents
or reverses PGE2-induced cAMP formation as measured by the
480/535 nm emission ratio of PKA sensors. (A) Response to 100
nM PGE2 is prevented by 5  M of the specific synthetic CaR modula-
tor NPS-R-476. (B) Another CaR agonist, spermine (used at 1 mM
throughout this study), largely inhibited the ratio change elicited by a
supramaximal dose (3  M) of PGE2; comparison with response to
100  M forskolin. (C) Similarly, spermine or 3 mM Ca
2  completely
blocked response to a lower dose (100 nM) of PGE2. (D) Acute addi-
tion of spermine during stimulation with 100 nM PGE2 reverses the
ratio elevation. (E) Experiments using the low-affinity cAMP indicator
R230K show smooth nonoscillatory decline in FRET ratio during
acute spermine (1 mM) treatment (bold trace); the thinner line repre-
sents control recording. (F) Comparison with the action of the Ca
2 -
mobilizing agonist 100  M carbachol. Experiments using the low-
affinity cAMP indicator R230K show a significantly reduced action
on the FRET ratio during acute carbachol treatment compared with
spermine treatment.JCB • VOLUME 171 • NUMBER 2 • 2005 306
(Fig. 2 C; n   16/19 cells in four experiments for spermine,
and n   15/15 cells in three experiments for 3 mM Ca
2 ).
Thus, preexposure to a variety of CaR agonists effectively pre-
vented the increase in cAMP production.
CaR stimulation was also able to reverse cAMP genera-
tion in cells previously stimulated with PGE2 or other agonists.
Spermine addition at the peak of the PGE2-induced cAMP ele-
vation caused a reversal of the ratio, as measured with this
PKA-based probe (Fig. 2 D; n   69 cells in eight experiments).
However, we noted that in some experiments using this proto-
col, the inhibitory response to spermine addition occurred with
some delay. We were concerned that we might be missing im-
portant dynamic information as the peak of the ratio change re-
ported by this very sensitive probe approached saturation. We
therefore performed additional experiments (Fig. 2 E) using a
version of the cAMP probe (“R230K”) in which the RII regula-
tory subunit had been engineered with a reduced affinity for
cAMP (Mongillo et al., 2004). The low-affinity reporter had
an estimated EC50 value for cAMP-dependent dissociation of
PKA of  31  M (vs. submicromolar dissociation for the wild-
type [WT] probe; Mongillo et al., 2004). Fig. 2 D also shows
that the profile of cAMP reduction during CaR activation was a
smooth monotonic function (typical of 13 cells in four experi-
ments; control trace typical of 23 cells in five experiments).
In experiments similar to those in Fig. 2 D, we compared
the acute action of the Ca
2 -mobilizing agonist carbachol on
the reversal of the 480/535 emission ratio during PGE2-stimulated
cAMP production, as measured with the R230K low-affin-
ity probe (Fig. 2 F; n   29 cells in four experiments). The
inhibitory action of carbachol was significantly less (only
 35%) than that elicited by spermine (normalized rate of de-
cline –0.006   0.001 SD for carbachol vs. –0.017   0.001 SD
during spermine; P   0.000001) and occurred with a slight
delay. Carbachol was also unable to completely prevent the
480/535 emission ratio increase during PGE2 stimulation in ex-
periments similar to those shown in Fig. 2 (A–C; and not de-
picted; n   13 cells in two experiments). Because HEK 293
cells apparently do not express G i-coupled muscarinic M2 re-
ceptors (Stope et al., 2003), we thought that the increase in intra-
cellular Ca
2  elicited by carbachol stimulation might account for
the modest inhibitory action seen in these experiments.
Reciprocal modulation of cAMP and 
Ca
2  pathways
Parallel experiments were performed with fura-2–loaded HEK
CaR cells to examine whether PGE2 had any effect on the pat-
tern of intracellular Ca
2  signaling. CaR stimulation elicits ro-
bust and long-lasting oscillations in [Ca
2 ]i (Breitwieser and
Gama, 2001; Young and Rozengurt, 2002; De Luisi and Hofer,
2003). As shown in Fig. 3 A, stimulation with spermine alone
gave rise to Ca
2  oscillations with a frequency of 1.78   0.03
per minute (n   122 cells in four experiments). This frequency
was dramatically increased after acute PGE2 addition (2.27  
0.06; P   0.0001), until the spikes fused into an elevated pla-
teau after  2 min (1.85   0.08 min). A third exposure to sper-
mine after PGE2 washout elicited oscillations that were faster
than the control (2.41   0.05; P   0.0001, compared with the
first stimulation), indicating that the effect of PGE2 was some-
what prolonged. The amplitude of the spikes was also signifi-
cantly affected by PGE2, with the overall effect being an in-
creased delivery of Ca
2  to the cytoplasm. As shown in Fig. 3 B,
a 3-min preexposure to PGE2 (when [cAMP] is typically near
its maximum; see Fig. 2 D) dramatically changed the profile of
the spermine response. We observed a few initial rapid spikes,
which eventually fused into a prolonged plateau after 2.2  
0.13 min (n   118 cells in four experiments). A third challenge
with spermine yielded a persistent effect on oscillation fre-
quency compared with the first control stimulation (2.03  
0.03 spikes per minute in control vs. 2.66   0.04 for third stim-
ulation; P   0.0001). Similar results were obtained when car-
bachol was used in place of spermine (not depicted; n   90
cells in four experiments). Although the carbachol-stimulated
Ca
2  oscillations under control conditions were typically much
less robust than those observed during spermine stimulation,
the pattern of initial increase in oscillation frequency that fused
into a sustained plateau was still dependably observed. Fig. 3 C
shows that the frequency of oscillations recorded during three
sequential control stimulations with spermine were very consis-
tent (n   87 cells in four experiments; no statistical difference).
The data on oscillation frequency are summarized in Fig. 3 D.
Results very similar to those shown in Fig. 3 (A and B)
were obtained when cAMP was elevated by a variety of means
using 100 nM VIP (2.13   0.05 oscillations per minute in con-
trol vs. 2.41   0.08 with VIP; n   51 cells; P   0.001), 100
nM isoproterenol (2.22   0.05 oscillations per minute in con-
trol vs. 2.63   0.08 with isoproterenol; n   63 cells; P  
0.0001), or 100  M forskolin (2.34   0.07 oscillations per
minute in control vs. 2.70   0.10 with forskolin after third
stimulation; n   60 cells; P   0.003). Experiments with the
membrane-permeable cAMP analogue Sp-8-Br-cAMPS sug-
gest that cAMP elevation by itself and not other elements of the
signal transduction cascade proximal to cAMP production
were sufficient for the enhancement of Ca
2  signaling. 200  M
of the “potent” cAMP analogue Sp-8-Br-cAMPS caused the
cAMP/FRET ratio to increase, albeit very slowly compared
with native cAMP-generating agonists (not depicted; n   31
cells in five experiments). Repeating the same maneuver in ex-
periments with fura-2–loaded cells showed that acute addition
of Sp-8-Br-cAMPS during Ca
2  spiking was able to reproduce
the effect induced by PGE2 shown in Fig. 3 (1.94   0.02 spikes
per minute in control vs. 2.69   0.03 in the presence of cAMP
analogue; n   135 cells in four experiments; P   0.00001).
Similar effects were achieved when cells were treated with
Sp-8-Br-cAMPS before spermine stimulation (not depicted;
2.16   0.04 spikes per minute in control vs. 2.73   0.04 in the
presence of cAMP analogue; n   102 cells in four experi-
ments; P   0.000001).
We did not examine in detail the mechanisms accounting
for the ability of cAMP to potentiate spermine or carbachol-
stimulated Ca
2  signaling in HEK CaR cells. This phenomenon
may derive from increased excitability of the InsP3 receptor be-
cause of PKA phosphorylation (for review see Bruce et al.,
2003), as described previously in parotid acinar cells (Bruce et
al., 2002). However, as shown in the subsequent sections, theTERMINATION OF cAMP SIGNALS • GERBINO ET AL. 307
conversion to a pattern of sustained Ca
2  delivery in the pres-
ence of cAMP has important implications for the regulatory
feedback of Ca
2  on cAMP signaling.
Elevation of intracellular Ca
2  affects 
cAMP production
In the parathyroid gland and some other cell models, CaR is a
pleiotropic receptor that can simultaneously increase [Ca
2 ]i and
inhibit cAMP formation via G i. The data of Fig. 2 F provided
some initial hints that intracellular Ca
2  may influence cAMP
levels in HEK cells. We next attempted to dissect the relative
contributions of Ca
2  signaling and putative G i-dependent
actions on CaR-mediated inhibition of cAMP production in
HEK 293 cells.
We first examined the actions of a large, single, “artifi-
cial” pulse of [Ca
2 ]i on cAMP formation in HEK 293 WT
cells, which do not express CaR. Before the start of the experi-
ment, WT cells were treated with the irreversible sarco/endo-
plasmic reticulum Ca
2 -ATPase pump inhibitor thapsigargin to
deplete intracellular Ca
2  stores. Cells were initially main-
tained in Ca
2 -free solution. Under these conditions, it is ex-
pected that readmission of Ca
2  to the bath will provoke a large
entry of Ca
2  into the cell because of influx through capacitative
Ca
2  entry pathways (Berridge et al., 2000). Parallel experi-
ments with fura-2 showed that addition of 5 mM Ca
2  resulted
in a large increase in [Ca
2 ]i (Fig. 4 A, right), comparable in
amplitude with the initial peak of the agonist-evoked Ca
2 
spike (n   110 cells in four experiments). In measurements us-
ing the PKA-FRET indicator under the same conditions, 5 mM
Ca
2  administered during the peak of PGE2-stimulated cAMP
production (100 nM PGE2) completely and reversibly decreased
the ratio increase (Fig. 4 A; n   28 cells in six experiments),
although with a small delay.
We found similar results when we used a different exper-
imental protocol to generate a persistent increase in [Ca
2 ]i in
HEK 293 CaR cells. 10  M ionomycin, a Ca
2  ionophore that
releases internal Ca
2  stores and promotes Ca
2  entry from the
extracellular space (as well as activates store-operated channels
via store depletion), was able to completely abolish both PGE2-
and forskolin-induced cAMP elevations, but only in the presence
of external Ca
2  (Fig. 4 B, left; n   28 cells in four experi-
ments). As shown in Fig. 4 B (right), however, the responses to
both PGE2 and forskolin were evident during ionomycin treat-
ment in the absence of external Ca
2  (n   28 cells in four ex-
periments). Under these conditions, ionomycin is expected to
yield only a transient ( 2-min duration) increase in intracellular
Ca
2  because of store release. These experiments confirm that
intracellular Ca
2  was indeed able to effectively modulate
cAMP levels in HEK 293 cells and are in agreement with pre-
vious reports that Ca
2  entering the cell via store-operated
channels preferentially regulates cAMP production by AC
(Cooper, 2003). This explanation is also consistent with the
data shown in Fig. 2 F, in which acute stimulation with the
Figure 3. Stimulation of cAMP-generating pathways alters CaR-mediated
intracellular Ca
2  oscillations as measured by fura-2 in HEK CaR cells.
(A) Spermine-stimulated Ca
2  oscillations (1 mM spermine) are signifi-
cantly enhanced in frequency and amplitude by acute addition of PGE2.
(B) PGE2 pretreatment converts the oscillatory spiking pattern into a pat-
tern of a large spike followed by several rapid oscillations that fuse into a
sustained plateau. (C) Consistent spiking pattern after three consecutive
control stimulations with spermine. (D) Summary of oscillation frequency
data (peaks per minute   SEM) corresponding to experimental protocols
shown in A–C. The left bar represents the first spermine stimulation; the
middle, gray bar represents the second stimulation; and the right bar
represents the third stimulation. ***, P   0.0001.
Figure 4. Cyclic AMP accumulation is sensitive to [Ca
2 ]i. The 480/535
nm emission ratio of the cAMP/FRET probe. (A) HEK WT cells. An artifi-
cial pulse of intracellular Ca
2  was generated by pretreating cells with
thapsigargin in Ca
2 -free solutions and then re-adding 5 mM Ca
2  at the
time point indicated during the 100-nM PGE2 response (left). The corre-
sponding time course for the [Ca
2 ]i increase as measured in separate
experiments by fura-2 is shown in the right panel. (B) HEK CaR cells. (left)
Persistent elevation of [Ca
2 ]i using 10  M ionomycin in the presence of
extracellular Ca
2  yields a persistent increase in [Ca
2 ]i (not depicted) that
inhibits both PGE2- and forskolin-induced increases in the cAMP/FRET ratio.
(right) Transient increase [Ca
2 ]i generated by ionomycin treatment in Ca
2 -
free solutions (not depicted) does not prevent PGE2- or forskolin-induced
increases in the cAMP/FRET ratio.JCB • VOLUME 171 • NUMBER 2 • 2005 308
Ca
2 -mobilizing agonist carbachol inhibited the cAMP signal,
although this inhibition was diminished significantly compared
with the potent actions of spermine.
The ability of CaR to block cAMP 
production is PTX sensitive
We used the specific blocker of G i, PTX, to determine
whether CaR expressed in HEK cells could also inhibit cAMP
production through this pathway. Previous attempts to charac-
terize this aspect of CaR signaling in HEK CaR cells using
conventional radioimmune assays for cAMP have been only
partially successful (Chang et al., 1998). During these experi-
ments we eliminated the Ca
2  signaling component by pretreat-
ing the cells with thapsigargin in Ca
2 -free solutions. Control
experiments (Fig. 5 A) demonstrate that store-depleted HEK
CaR cells maintained in Ca
2 -free solutions were still able to
repeatedly respond to PGE2 and forskolin (n   37/39 cells in
six experiments). Somewhat surprisingly, this response was en-
tirely abolished by spermine (Fig. 5 B; n   28/29 cells in four
experiments). This implies that activation of CaR is capable of
regulating cAMP signaling through a pathway entirely inde-
pendent of Ca
2 . However, the response to PGE2 was recov-
ered in the presence of spermine when G i, the link between
CaR and AC inactivation, was inhibited by PTX (n   19 cells
in five experiments; Fig. 5 C).
The preceding results demonstrate that CaR exerts a dual
action on cAMP signaling, working through intracellular Ca
2 
and PTX-sensitive pathways. Based on the strong oscillatory
pattern of the Ca
2  signal (Fig. 3, A–C), we wondered if condi-
tions existed under which cAMP would also display a complex
oscillatory or descending “staircase” profile. Such cAMP oscilla-
tions might arise from repetitive coupling of CaR to AC via G i,
or as a secondary consequence of intracellular Ca
2  spiking.
Fig. 6 A shows that in the absence of G i-mediated inhibi-
tion (PTX pretreatment), spermine still caused a smooth mono-
tonic reduction in the FRET ratio (compare with control in Fig.
2 E), and this occurred with a substantial delay (n   20 cells in
four experiments). We expected to see fluctuations or stepwise
decrements in cAMP because parallel experiments in fura-2–
loaded cells revealed initial persistence of Ca
2  oscillations
(similar to those observed in Fig. 3; not depicted) after PTX
treatment, and the data of Fig. 5 showed cAMP accumulation to
be very sensitive to intracellular Ca
2 . We considered the possi-
bility that the PKA-based sensors we were using had not been
fast enough to resolve rapid fluctuations in cAMP because a
relatively complex binding reaction involving four cAMP
Figure 5. CaR inhibits cAMP production through PTX-sensitive G i. Mea-
surements of the 480/535 nm emission ratio of the PKA-based sensor
were performed in thapsigargin-pretreated HEK CaR cells maintained in
Ca
2 -free solutions (to eliminate contributions from Ca
2  signaling). (A)
Control experiment showing two successive responses to 100 nM PGE2
followed by maximal response to 100  M forskolin. (B) 1 mM spermine
prevents PGE2-induced ratio elevation in the absence of Ca
2  signaling.
(C) Pretreatment with PTX rescues the PGE2 response, in spite of the pres-
ence of spermine.
Figure 6. Profile of the spermine-induced decline in cAMP after PTX
pretreatment as measured by PKA- and Epac-based sensors. (A) In PTX-
pretreated HEK CaR cells (100 ng/ml   16 h), spermine added during
the peak of PGE2 stimulation causes a smooth decline in the 480/535 nm
ratio, even though [Ca
2 ]i, as measured by fura-2, initially maintains an
oscillatory pattern under these conditions (not depicted). (B) A similar
smooth decline in the 480/535 nm emission ratio is observed when sper-
mine is added during the peak of the response to 5 nM PGE2 as measured
using the Epac sensor. (C) As in B, but in PTX-pretreated cells. (D) Concur-
rent fura-2 and FRET ratio measured in fura-2–loaded HEK CaR cells trans-
fected with the Epac sensor shows persistence of spermine-stimulated Ca
2 
oscillations in Epac-expressing cells, although there is significant optical
contamination of the FRET channel by the fura-2 signal.TERMINATION OF cAMP SIGNALS • GERBINO ET AL. 309
molecules and the dissociation of four PKA subunits is required
to see a change in FRET. However, a similar profile was ob-
served in experiments using the fast monomeric Epac-based
sensor described on the previous page. As shown in Fig. 6 B,
spermine addition during stimulation of cells with a low dose
(5 nM) of PGE2 caused a smooth reversible decline in the FRET
ratio. Fig. 6 C illustrates the powerful inhibitory effect of the
PTX-sensitive component of CaR stimulation on cAMP signal-
ing. After PTX pretreatment, the action of spermine-induced
Ca
2  signals can be examined in isolation. A smooth, slow de-
cline in the FRET ratio that occurred with a notable delay was
observed upon spermine addition. Concurrent measurements of
the 340:380 nm fura-2 excitation ratio and 480/535 nm FRET
emission ratio in fura-2–loaded HEK CaR cells expressing the
Epac sensor confirmed that the presence of Epac did not alter
Ca
2  oscillations (Fig. 6 D). However, we noted significant
“bleed through” of the fura-2 signal into the FRET channels
(see Materials and methods for details), giving rise to apparent
oscillations in the FRET ratio that were never observed in cells
not loaded with fura-2 (n   9 cells in five experiments).
In numerous experiments using the protocols shown in
Fig. 2 (A–F; on hundreds of individual cells) using both low-
affinity WT PKA-based indicators and varying doses and
combinations of receptor agonists, we observed only a regular,
uniform decline in the ratio after CaR activation. The question
remains, why are fluctuations in the FRET ratio, driven by intra-
cellular Ca
2  spikes, not evident in these experiments? The fol-
lowing data show that the frequency and duration of Ca
2  spiking
are critical determinants of whether the inhibitory actions of in-
tracellular Ca
2  are translated to the cAMP signaling pathway.
We generated repetitive artificial Ca
2  spikes in HEK WT
cells using a pattern that mimicked spermine-stimulated Ca
2 
oscillations in HEK CaR cells. WT cells were pretreated with
thapsigargin in Ca
2 -free solutions, and intermittent pulses of
Ca
2  (1 mM) were applied during PGE2-stimulated cAMP ac-
cumulation. As shown in Fig. 7 A, with a frequency of one Ca
2 
spike (lasting 1 min) every 2 min, no effect could be discerned
on the FRET ratio (n   8 cells in three experiments). Fig. 7 B
shows that the low-affinity PKA-based indicator should, in
principle, be able to respond to alterations in [cAMP] on the
minute time scale. In these experiments, cells were permeabi-
lized with digitonin in an intracellular-like buffer. Cells were
then alternately superfused for 1-min pulses with solutions con-
taining 30 or 50  M cAMP (n   9 cells in four experiments).
These seemingly high concentrations of cAMP were used be-
cause in situ calibration of the low-affinity probe revealed this
to be the range of [cAMP] levels achieved during stimulation
with 500 nM PGE2 (not depicted; n   12 cells in five experi-
ments). In contrast to the results of Fig. 7 A, when the frequency
and duration of the Ca
2  pulses were altered (one 3-min-long
spike every 6 min), distinctive stepwise reductions in Ca
2  were
evident (Fig. 7 C; n   22 cells in five experiments). It was con-
sistently observed that  1 min was required after admission of
Ca
2  in the superfusion before the FRET ratio began to decline
(during the first Ca
2  pulse, the ratio started to decrease only af-
ter 1.63   0.60 min, for the second Ca
2  pulse, after 1.40  
0.66 min, and for the third pulse, after 1.22   0.70 min; n   22
cells in five experiments), explaining why the pattern of rapid
Ca
2  spiking in Fig. 7 A failed to elicit any effect. These results
indicate that in this model system the cAMP machinery is
immune to rapid Ca
2  spiking but does respond to large
static increases in Ca
2  (as sensed by PKA and Epac), which
sets cAMP at a new, reduced level.
Discussion
In vivo, cells are bombarded with a variety of extracellular first
messengers that may have complementary or antagonistic ac-
tions. These stimuli must be integrated dependably at the level
of intracellular second messenger cascades if the appropriate
biological endpoint is to be achieved. In addition, although
there are many specific cell-surface receptors, there are rela-
tively few second messengers. An emerging concept in the
field of signal transduction is the existence of signaling net-
works that exploit complex spatiotemporal patterns of second
messenger molecules, allowing encoding of an expanded rep-
ertoire of messages using limited numbers of messengers
(Zaccolo and Pozzan, 2003).
In this study we examined the interactions of the widely
expressed GPCR, CaR, with other receptors linked to cAMP
generation. Our data show that in HEK cells, CaR is exception-
ally competent in terminating cAMP signaling initiated by the
inflammatory mediator PGE2 (Figs. 2 and 6) as well as cAMP
Figure 7. PKA dissociation is immune to high-frequency Ca
2  oscillations.
Parallel measurements of [Ca
2 ]i using fura-2 and cAMP using the low-
affinity R230K version of the PKA/FRET probe in HEK WT cells. (A) Effect of
high-frequency artificial Ca
2  pulses during peak of PGE2 response in cells
preincubated in thapsigargin/Ca
2 -free solutions. (B) Control experiment in
digitonin-permeabilized WT cells alternately superfused with 50 and 30
 M cAMP for 1 min each shows the response time of the probe to rapid
fluctuations in [cAMP]. (C) Low-frequency, long-duration Ca
2  pulses
generate complex staircase patterns of cAMP in HEK WT cells.JCB • VOLUME 171 • NUMBER 2 • 2005 310
signals generated by isoproterenol and VIP (not depicted).
The reasons for this potent action are threefold. First is the
somewhat predictable inhibition through the classical PTX-
sensitive G i pathway that we demonstrated here to be very ef-
fective by itself in HEK CaR cells (Figs. 5 and 6). Although it
was known from prior biochemical studies that CaR is able to
interact with G i in several cell types, the use of sensitive
FRET-based imaging techniques allowed us to examine this in-
teraction with unprecedented spatiotemporal detail in single
living cells. The second reason CaR stimulation is so efficient
in preventing or reversing cAMP signaling is that it activates
intracellular Ca
2  signaling cascades. Our data demonstrate
that cAMP accumulation was sensitive to [Ca
2 ]i in HEK cells
(Fig. 4), as has been described previously for other cell models.
Under control conditions, these Ca
2  signals are manifested as
oscillations, which persist with very little desensitization as
long as CaR agonists are present. However, in the presence of
cAMP, this oscillatory pattern of Ca
2  signaling was ultimately
converted to a larger, sustained Ca
2  elevation that was shown
here to be much more effective in modulating cAMP levels
(Figs. 3 and 4). This enhancement of the Ca
2  signal by cAMP
constitutes the third mechanism that serves to reinforce the
prompt termination of the cAMP elevation in HEK CaR cells.
CaR and other receptors that are able to interact through
both G i and Ca
2  may be useful targets for pharmacological
control of cAMP signaling in several tissues. Of course, it must
be kept in mind that the action of Ca
2  on cAMP signaling will
depend strongly on the particular repertoire of PDE and AC
isoforms expressed in a given cell type and whether they are
activated, unaffected, or inhibited by Ca
2  (Cooper et al., 1995;
for review see Bruce et al., 2003). Landa et al. (2005) recently
provided evidence for rapid Ca
2 -dependent augmentation of
cAMP signaling using Epac-based cAMP sensors in insulin-
secreting MIN6   cells, a cell type that expresses a very differ-
ent panel of ACs and PDEs. de Jesus Ferreira et al. (1998) de-
scribed coexpression of Ca
2 -inhibitable (type 6) AC and CaR
in the cortical thick ascending limb of the kidney and further
showed potent antagonism of cAMP signaling during CaR
stimulation by physiological levels of extracellular [Ca
2 ]. CaR
is also known to be concentrated in neuronal synapses, where
predictions from modelling and direct measurements have
shown significant depletions in extracellular [Ca
2 ] during
neuronal activity because of entry though voltage-operated
Ca
2  channels (Egelman and Montague, 1999; Cohen and
Fields, 2004). Under these conditions, it might be predicted
that lowering extrasynaptic [Ca
2 ] would relieve repression of
cAMP signaling through CaR’s interaction with G i (keeping
in mind, however, that Ca
2 -activated ACs expressed in neu-
ronal cells might mitigate this effect). This type of regulation
could have profound implications for learning and memory.
We recently provided functional evidence that physiological
fluctuations in extracellular [Ca
2 ] can affect the secretory ac-
tivity of the intact gastric mucosa through a PTX-sensitive in-
teraction of CaR with the cAMP signaling pathway (Caroppo
et al., 2004). We termed this effect the “third messenger” ac-
tion of Ca
2  because CaR activation resulted from dynamic
extracellular  [Ca
2 ] fluctuations secondary to stimulation of
the tissue with a Ca
2 -mobilizing cholinergic agonist. Interest-
ingly, as has been reported in several other cell systems, direct
CaR stimulation did not produce an intracellular Ca
2  signal in
gastric cells (Hofer et al., 2004). These findings highlight the
complexity of signaling networks in vivo, where the effects of
[Ca
2 ] changes in both intracellular and extracellular compart-
ments must be taken into account in tissues where CaR or other
Ca
2  sensors are expressed.
We undertook this study with the initial expectation
that cAMP, as reported by cAMP-dependent conformational
changes of two major cellular targets of the cAMP signal, PKA
and Epac, might undergo “oscillations” or other dynamic
fluctuations during concurrent stimulation of CaR and other
cAMP-generating receptors, based on the robust oscillatory
Ca
2  response during CaR activation in HEK CaR cells. Gor-
bunova and Spitzer (2002) reported slow, spontaneous cAMP
transients lasting several minutes in embryonic Xenopus laevis
spinal neurons that followed bursts of spontaneous Ca
2  oscil-
lations. These investigators identified optimal patterns of Ca
2 
spiking during the preceding cluster of Ca
2  oscillations that
gave rise to these intermittent cAMP elevations. We examined
the cAMP signal over a much shorter time frame and only dur-
ing contemporaneous stimulation of CaR and cAMP pathways.
In our studies we only observed a smooth monotonic decline in
the FRET ratio under these conditions. We cannot exclude the
possibility that complex spatiotemporal cAMP dynamics occur
in localized domains (Tasken and Aandahl, 2004) and are
therefore undetectable by the PKA- or Epac-based sensors.
Rich et al. (2001a) provided evidence for localized cAMP sig-
nals under the plasma membrane of HEK cells that differed
temporally from those of the bulk cytoplasm, as measured by
currents through transfected cyclic nucleotide gated cation
channels. However, our data clearly show that the relatively
fast frequencies of Ca
2  oscillations that are typical of stimula-
tion with native Ca
2 -mobilizing agonists cannot exert effects
on PKA subunit dissociation (Fig. 7 A) or Epac conformational
changes (Fig. 6, B and C). This important result means that, in
principle, high-frequency Ca
2  signaling can take place with-
out affecting the activity of two of the major targets of the in-
tracellular cAMP signal, PKA and Epac.
Our data revealed a complex twist to this story, namely,
that during concurrent stimulation of cAMP and Ca
2  path-
ways, cAMP initially causes the Ca
2  oscillation frequency to
increase. However, these spikes eventually fuse into a persis-
tent Ca
2  elevation, a pattern that is effective in inhibiting
cAMP accumulation. This may help explain why the effects
of Ca
2 -mobilizing agonists (spermine and carbachol) on the
FRET ratio are only evident in Fig. 2 F and Fig. 6 (A and C) after
some delay. Initially, rapid Ca
2  spiking would not be effective
in turning off cAMP production, but after several minutes,
during the elevated plateau phase of the signal, Ca
2  would be
able to exert its inhibitory action on cAMP.
Application of artificial low-frequency, long-duration sig-
nals yielded a complex staircase profile of cAMP decline (Fig.
7 C). This mode of low-frequency, long-duration Ca
2  spiking
has not been observed in this cell type during a single stimulation
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during a brief ( 3-min duration) stimulation with a Ca
2 -mobi-
lizing agonist in the presence of cAMP. Because the molecular
targets of cAMP (e.g., type I and II regulatory subunits of PKA
and Epac) have a wide range of affinities for cAMP, it is possible
that a large uniform Ca
2  pulse of moderate duration could serve
to “reset” [cAMP] to a lower level that favors activation of a
higher affinity cAMP-binding target. This may be one more ex-
ample of how complex spatial and temporal interactions between
different signaling systems can be used to create unique messen-
ger profiles that elicit diverse biological endpoints.
Materials and methods
Cell culture
HEK 293 cells stably expressing the human CaR and WT HEK 293 were
grown in high-glucose DME   glutamax (Life Technologies) supplemented
with 10% FBS containing 10 U/ml penicillin and 10 mg/ml streptomycin.
Cells were maintained in a humidified incubator under 5% CO2 and 95%
O2 at 37 C.
FRET-based measurement of cAMP in single cells
Intracellular cAMP was imaged in single cells expressing a genetically en-
coded FRET-based indicator described previously (Zaccolo and Pozzan,
2002; Zaccolo, 2004). In brief, the probe was generated by fusing the
regulatory and the catalytic subunits of PKA to CFP and YFP, respectively.
When [cAMP] is low, PKA is in its holomeric form and the two fluoro-
phores, CFP and YFP, are separated physically by a few nanometers.
The excitation energy of the CFP (“donor,” 440 nm) can pass via Förster
energy transfer to the acceptor molecule, YFP, which in turn emits at its
own wavelength (535 nm). This gives rise to maximal FRET. When intra-
cellular cAMP rises, the two PKA subunits dissociate and FRET is abolished.
FRET can be estimated as the ratio of donor (480 nm) to acceptor emis-
sion (535 nm) intensities when cells are excited at the donor excitation
wavelength (440 nm). Changes in the fluorescence emission ratio (480/
535 nm) are directly correlated to changes in catalytic and regulatory sub-
unit association and thus to cAMP levels (Mongillo et al., 2004).
A second type of sensor for cAMP relying on the cAMP-dependent
conformational change of the monomeric cAMP-binding protein Epac
(monitored as a change in FRET between CFP- and YFP-labeled domains)
was also used. CFP-Epac( DEP)-YFP, a catalytically inactive version of the
cAMP effector protein Epac with a cytosolic localization (Ponsioen et al.,
2004), was a gift from K. Jalink and colleagues (the Netherlands Cancer
Institute, Amsterdam, Netherlands). The 480/535 nm emission ratio (exci-
tation at 440 nm) of this fast cAMP sensor was monitored as for the PKA-
based probes.
HEK 293 CaR and HEK 293 WT cells were plated onto sterilized
glass coverslips resting in the bottom of 60-mm plastic culture dishes and
transiently transfected with cAMP probes using effectene transfection re-
agent (QIAGEN). Imaging experiments were performed on subconfluent
cells 2 d after the transfection using a ratio imaging setup running
Metafluor software (Universal Imaging Corp.). Coverslips with probe-trans-
fected cells were mounted in an open-topped perfusion chamber (Series
20; Warner Instrument Corp.) and placed on the heated stage of an in-
verted microscope (TE200; Nikon) equipped with a CFP/YFP FRET filter
set (XF88-2/E; Omega Optical). Cells were excited at 440 nm for 80 ms
through a 40  (NA 1.4) oil immersion objective (455-nm DRLP). Emitted
light was captured alternately at 480 and 535 nm using a microproces-
sor-controlled filter wheel placed in the emission light path. Pairs of fluores-
cence images at the two wavelengths were captured by a charge-coupled
device camera (ORCA ER; Hamamatsu) every 5 s and converted to a ratio
image by the Metafluor software.
Measurement of [Ca
2 ]i
Parallel measurements of cytoplasmic-free [Ca
2 ] were performed using
fura-2–AM–loaded HEK 293 cells as described previously (De Luisi and
Hofer, 2003). Using the imaging system described for cAMP, cells were ex-
cited alternately at 340 and 380 nm for 80 ms through a 40  (NA 1.4) oil
immersion objective. The excitation wavelengths were generated using a
computer-controlled filter wheel (Sutter Instrument Co.) placed in the path of
a 100-W mercury light source. Pairs of fluorescence images (emission col-
lected  510 nm) were captured by the charge-coupled device camera ev-
ery 4 s and converted to a ratio image by the Metafluor software.
Concurrent measurements of fura-2 and CFP-YFP FRET
HEK CaR cells expressing the Epac sensor were loaded with fura-2 and
sequential fura-2, and CFP/YFP ratio pairs were collected, keeping only
the 455-nm dichroic mirror in place (Landa et al., 2005). Significant
contamination of the FRET ratio with the fura-2 signal was noted using
this configuration.
Experiments on digitonin-permeabilized HEK cells expressing R230K PKA-
based sensor
As described previously (Hofer and Machen, 1993), cells were rinsed
briefly in a high K
  solution (125 mM KCI, 25 mM NaCI, 0.1 mM MgCl2,
and 10 mM Hepes, pH 7.20) and then exposed for 2–3 min to an intra-
cellular buffer (the same solution with free [Ca
2 ] clamped to 170 nM
using Ca
2 /EGTA buffers and supplemented with 1 mM Na2ATP) also
containing 5  g/ml digitonin at 37 C. After plasma membrane permeabi-
lization, cells were continuously superfused with intracellular buffer (with-
out digitonin, but containing varying [cAMP]). An in situ calibration estab-
lished that 500 nM PGE2 caused cAMP levels to increase to  30–50  M,
as measured by the low-affinity R230K sensor.
Solutions and materials
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich.
Experiments were performed with a Ringer’s solution containing 121 mM
NaCl, 2.4 mM K2HPO4, 0.4 mM KH2PO4, 1.2 mM CaCl2, 1.2 mM MgCl2,
10 mM glucose, and 10 mM Hepes/NaOH, pH 7.40. Bradykinin, ionomy-
cin, and Sp-8-Br-cAMPS (adenosine 3 , 5 -cyclic monophosphorthioate,
8-Bromo, Sp-Isomer, and Na
  salt) were obtained from Calbiochem-Nova-
biochem; fura-2–AM and BAPTA-AM were obtained from Invitrogen. NPS-
R-467 was obtained from E. Nemeth (NPS Pharmaceuticals, Salt Lake
City, UT). When DMSO or ethanol was used as a solvent, the final solvent
concentration never exceeded 0.01 or 0.1%, respectively.
Statistical analysis
At the end of each experiment using the cAMP probes, cells were super-
fused with a supramaximal dose (50–100  M) of forskolin, a reliable acti-
vator of AC. Because cells were occasionally fluorescent but nevertheless
nonresponsive to agonists (possibly because of improper folding or target-
ing of the probe), only the cells that responded to the forskolin with a ro-
bust ratio increase were statistically averaged. Statistical significance was
determined using a paired t test. Data from several cells in a particular ex-
perimental run were averaged, and experiment averages were used to
calculate the mean   SEM. Traces shown are typical of at least three simi-
lar experiments unless otherwise noted.
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